Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report

BACKGROUND: After acute infection of Epstein-Barr virus, Epstein-Barr virus-infected B cells survive but usually do not show clonal proliferation. However, Epstein-Barr virus-infected B cells occasionally acquire a proliferative capacity that provokes clonal lymphoproliferative disorders. We herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Koki, Ikeda, Kazuhiko, Ogawa, Kazuei, Sukegawa, Masumi, Sano, Takahiro, Kimura, Satoshi, Suzuki, Osamu, Hashimoto, Yuko, Takeishi, Yasuchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997747/
https://www.ncbi.nlm.nih.gov/pubmed/27557810
http://dx.doi.org/10.1186/s13256-016-1009-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997747/
https://www.ncbi.nlm.nih.gov/pubmed/27557810
http://dx.doi.org/10.1186/s13256-016-1009-1

Ejemplares similares